Comment on 'Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6'

MLA

Mario Corbellino, et al. “Comment on ‘Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6.’” Clinical Pharmacokinetics, vol. 60, Apr. 2021, pp. 829–31. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8b3d1c5d1b60fb45963c59dcdff157b3&authtype=sso&custid=ns315887.

APA

Mario Corbellino, Valeria Cozzi, Dario Cattaneo, Marta Fusi, & Cristina Gervasoni. (2021). Comment on “Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6.” Clinical Pharmacokinetics, 60, 829–831.

Chicago

Mario Corbellino, Valeria Cozzi, Dario Cattaneo, Marta Fusi, and Cristina Gervasoni. 2021. “Comment on ‘Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6.’” Clinical Pharmacokinetics 60 (April): 829–31. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8b3d1c5d1b60fb45963c59dcdff157b3&authtype=sso&custid=ns315887.